Literature DB >> 25188449

Dynamic analysis of GH receptor conformational changes by split luciferase complementation.

Ying Liu1, Philip A Berry, Yue Zhang, Jing Jiang, Peter E Lobie, Ramasamy Paulmurugan, John F Langenheim, Wen Y Chen, Kurt R Zinn, Stuart J Frank.   

Abstract

The transmembrane GH receptor (GHR) exists at least in part as a preformed homodimer on the cell surface. Structural and biochemical studies suggest that GH binds GHR in a 1:2 stoichiometry to effect acute GHR conformational changes that trigger the activation of the receptor-associated tyrosine kinase, Janus kinase 2 (JAK2), and downstream signaling. Despite information about GHR-GHR association derived from elegant fluorescence resonance energy transfer/bioluminescence resonance energy transfer studies, an assessment of the dynamics of GH-induced GHR conformational changes has been lacking. To this end, we used a split luciferase complementation assay that allowed detection in living cells of specific ligand-independent GHR-GHR interaction. Furthermore, GH treatment acutely augmented complementation of enzyme activity between GHRs fused, respectively, to N- and C-terminal fragments of firefly luciferase. Analysis of the temporal pattern of GH-induced complementation changes, pharmacological manipulation, genetic alteration of JAK2 levels, and truncation of the GHR intracellular domain (ICD) tail suggested that GH acutely enhances proximity of the GHR homodimer partners independent of the presence of JAK2, phosphorylation of GHR-luciferase chimeras, or an intact ICD. However, subsequent reduction of complementation requires JAK2 kinase activity and the ICD tail. This conclusion is in contrast to existing models of the GHR activation process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25188449      PMCID: PMC4213363          DOI: 10.1210/me.2014-1153

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  65 in total

1.  Firefly luciferase enzyme fragment complementation for imaging in cells and living animals.

Authors:  Ramasamy Paulmurugan; Sanjiv S Gambhir
Journal:  Anal Chem       Date:  2005-03-01       Impact factor: 6.986

2.  Detection of protein-protein interactions in live cells and animals with split firefly luciferase protein fragment complementation.

Authors:  Victor Villalobos; Snehal Naik; David Piwnica-Worms
Journal:  Methods Mol Biol       Date:  2008

3.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

4.  The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

Authors:  Michael Hedvat; Dennis Huszar; Andreas Herrmann; Joseph M Gozgit; Anne Schroeder; Adam Sheehy; Ralf Buettner; David Proia; Claudia M Kowolik; Hong Xin; Brian Armstrong; Geraldine Bebernitz; Shaobu Weng; Lin Wang; Minwei Ye; Kristen McEachern; Huawei Chen; Deborah Morosini; Kirsten Bell; Marat Alimzhanov; Stephanos Ioannidis; Patricia McCoon; Zhu A Cao; Hua Yu; Richard Jove; Michael Zinda
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

Review 5.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

6.  Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.

Authors:  Ning Yang; John F Langenheim; Xiangdong Wang; Jing Jiang; Wen Y Chen; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2007-12-20

7.  Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice.

Authors:  Yuji Ikeno; Gene B Hubbard; Shuko Lee; Lisa A Cortez; Christie M Lew; Celeste R Webb; Darlene E Berryman; Edward O List; John J Kopchick; Andrzej Bartke
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-19       Impact factor: 6.053

8.  An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway.

Authors:  Scott W Rowlinson; Hideo Yoshizato; Johanna L Barclay; Andrew J Brooks; Stuart N Behncken; Linda M Kerr; Kirstin Millard; Kathryn Palethorpe; Katherine Nielsen; Jodie Clyde-Smith; John F Hancock; Michael J Waters
Journal:  Nat Cell Biol       Date:  2008-05-18       Impact factor: 28.824

9.  Imaging ligand-dependent activation of CXCR7.

Authors:  Kathryn E Luker; Mudit Gupta; Jessica M Steele; Bradley R Foerster; Gary D Luker
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

Review 10.  Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.

Authors:  Niels Møller; Jens Otto Lunde Jørgensen
Journal:  Endocr Rev       Date:  2009-02-24       Impact factor: 19.871

View more
  8 in total

1.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

2.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11

3.  Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.

Authors:  Ying Liu; Jing Jiang; Bradford Lepik; Yue Zhang; Kurt R Zinn; Stuart J Frank
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

4.  GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.

Authors:  Ying Liu; Yue Zhang; Jing Jiang; Peter E Lobie; Ramasamy Paulmurugan; John F Langenheim; Wen Y Chen; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2016-03-22

Review 5.  JAK2 activation by growth hormone and other cytokines.

Authors:  Michael J Waters; Andrew J Brooks
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

6.  Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B.

Authors:  Takahiro Sawada; Daiki Arai; Xuefeng Jing; Masayasu Miyajima; Stuart J Frank; Kazushige Sakaguchi
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  Differential tissue response to growth hormone in mice.

Authors:  Ryan Berry; Graham R McGinnis; Ronadip R Banerjee; Martin E Young; Stuart J Frank
Journal:  FEBS Open Bio       Date:  2018-05-23       Impact factor: 2.693

Review 8.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.